产品资料

Anti-PIM1 Antibody

如果您对该产品感兴趣的话,可以
产品名称: Anti-PIM1 Antibody
产品型号:
产品展商: 其它品牌
产品文档: 无相关文档

简单介绍

Anti-PIM1 Antibody


Anti-PIM1 Antibody  的详细介绍
Name: Anti-PIM1 Antibody
See all PIM1 primary antibodies
Description: Rabbit monoclonal antibody to PIM1.
Applications: WB, IHC, IF
Dilutions: WB: 1:500 - 1:2000, IHC: 1:50 - 1:200, ICC: 1:50 - 1:200, IF: 1:50 - 1:100.
Reactivity: Human, Mouse
Immunogen: Recombinant protein of human PIM1.
Host: Rabbit
Clonality: Monoclonal
Isotype: IgG
Conjugate: Unconjugated
Purification: Affinity purification.
Product Form: Liquid
Formulation: Supplied in Phosphate Buffered Saline, pH 7.30, with 0.02% Sodium Azide and 50% Glycerol.
Storage: Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Function: Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3). Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase of transcriptional activity. The stabilization of MYC exerted by PIM1 might explain partly the strong synergism between these two oncogenes in tumorigenesis. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1. Phosphorylation of MAP3K5, an other proapoptotic protein, by PIM1, significantly decreases MAP3K5 kinase activity and inhibits MAP3K5-mediated phosphorylation of JNK and JNK/p38MAPK subsequently reducing caspase-3 activation and cell apoptosis. Stimulates cell cycle progression at the G1-S and G2-M transitions by phosphorylation of CDC25A and CDC25C. Phosphorylation of CDKN1A, a regulator of cell cycle progression at G1, results in the relocation of CDKN1A to the cytoplasm and enhanced CDKN1A protein stability. Promote cell cycle progression and tumorigenesis by down-regulating expression of a regulator of cell cycle progression, CDKN1B, at both transcriptional and post-translational levels. Phosphorylation of CDKN1B,induces 14-3-3-proteins binding, nuclear export and proteasome-dependent degradation. May affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3. Acts also as a regulator of homing and migration of bone marrow cells involving functional interaction with the CXCL12-CXCR4 signaling axis.
Tissue Specificity: Expressed primarily in cells of the hematopoietic and germline lineages. Isoform 1 and isoform 2 are both expressed in prostate cancer cell lines.
Sequence Similarities: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. PIM subfamily.
Post-Translational Modification: Autophosphorylated on both serine/threonine and tyrosine residues. Phosphorylated. Interaction with PPP2CA promotes dephosphorylation.
Cellular Location: Cytoplasm. Nucleus.
Database Links:
  • Entrez Gene: 5292?Human
  • Entrez Gene: 18712?Mouse
  • Omim: 164960?Human
  • SwissProt: P11309?Human
  • SwissProt: P06803?Mouse
  • Unigene: 81170?Human
  • Unigene: 405293?Mouse
  • Unigene: 485038?Mouse
  • Synonyms:
  • Oncogene PIM 1 Antibody
  • Oncogene PIM1 Antibody
  • PIM Antibody
  • PIM 1 Antibody
  • Pim 1 kinase Antibody
  • pim 1 kinase 44 kDa isoform Antibody
  • Pim 1 oncogene Antibody
  • pim 1 oncogene (proviral integration site 1) Antibody
  • PIM1 Antibody
  • pim1 kinase 44 kDa isoform Antibody
  • PIM1_HUMAN Antibody
  • Pim2 Antibody
  • PIM3 Antibody
  • Proto oncogene serine/threonine protein kinase Pim 1 Antibody
  • Proto-oncogene serine/threonine-protein kinase Pim-1 Antibody
  • Proviral integration site 1 Antibody
  • Proviral integration site 2 Antibody
  • Information: Target information shown above is from the UniProt Consortium.
    产品留言
    标题
    联系人
    联系电话
    内容
    验证码
    点击换一张
    注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
    2.如有必要,请您留下您的详细联系方式!

    沪公网安备 31011202007337号